Serum Institute of India

Premium

General

28 October, 2024

Grapevine: Imperial Blue, InsuranceDekho, Swiggy, JSW Energy, ADIA, Poonawalla in news

Barista founder Ravi S Deol, JSW Energy and Power Trust have either entered the race or made the cut to ......

Premium

TMT

21 October, 2024

How Poonawalla booked a premium ticket to Karan Johar's firm despite sharp income skid

Pune-based tycoon and head of Covishield vaccine maker, Serum Institute of India, Adar Poonawalla signed an agreement Monday to pick ......

Premium

Healthcare

16 May, 2024

Exclusive: Poonawalla's Serum Institute forays into medtech via acquisition

Serum Institute of India (SII), the world's biggest vaccine maker, has picked up a minority stake in a medical technology company, two ......

Premium

Healthcare

24 July, 2023

Advent may rope in new investor for Bharat Serums with neat valuation markup

Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a ......

Healthcare

25 April, 2023

Serum to double investment in PE-backed Biocon Biologics to $300 mn

A unit of Adar Poonawalla-led Serum Institute of India, the world's biggest vaccine maker, will double its investment to $300 ......

Premium

Finance

19 December, 2022

Poonawalla  to  target growth-stage firms with ₹1,000 cr fund

Adar Poonawalla, chief executive of Serum Institute of India, has sought regulatory approval to establish the Poonawalla Vision Fund to ......

Premium

Finance

06 April, 2022

India Alternatives garners 5x returns on its first exit from second fund

The family office of Adar Poonawalla, who is the CEO of the world's largest manufacturer of vaccines by volume, Serum ......

Healthcare

01 October, 2021

Serum Institute to sell bulk of its stake as Wellness Forever files for IPO

Wellness Forever Medicare Ltd, an omni-channel retail pharmacy chain backed by Adar Poonawalla, has filed for an initial public offering ......

Healthcare

17 August, 2021

Serum Institute to acquire 50% stake in India's largest vial maker Schott Kaisha

Vaccine maker Serum Institute of India has acquired a 50% stake in drug vial maker Schott Kaisha, the companies said ......

Healthcare

13 July, 2021

Russia's RDIF, India's SII to make Sputnik COVID-19 vaccine in India

The Russian Direct Investment Fund (RDIF) and Serum Institute of India (SII) unveiled plans on Tuesday to start producing Russia's ......